Bowel Habits May Be Tied to Severity of Menopause Symptoms
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — Perceived stress and some gastrointestinal symptoms are associated with menopausal symptoms, according to a study published online Oct. 3 in Menopause.Ieva Brimienė, M.D., from Vilnius University in Lithuan…
Learn MoreCommonly Used Drug Might Be New Treatment Option for IBS
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).In th…
Learn MoreFDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults
TUESDAY, Oct. 17, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).The approval was based on results from the ELEVATE UC phase 3 registr…
Learn MoreLas bacterias intestinales de un lobo podrían mejorar la salud de los perros domésticos
MIÉRCOLES, 11 de octubre de 2023 (HealthDay News) — Un tipo de bacteria intestinal encontrada en lobos salvajes podría ayudar a tratar a los perros domésticos que tienen una afección gastrointestinal común y debilitante.La nueva investigación en un l…
Learn MoreA Wolf’s Gut Bug Might Boost Health of Domestic Dogs
MONDAY, Oct. 9, 2023 (HealthDay News) — A type of gut bacteria found in wild wolves could help treat domestic dogs who have a common, debilitating gastrointestinal condition. New research in an Oregon wolf discovered a novel strain of Paenibacillus b…
Learn MoreEstudio confirma riesgo de problemas gastrointestinales en consumidores de Wegovy y Ozempic
VIERNES, 6 de octubre de 2023 (HealthDay News) — Aunque muchos han elogiado los poderes de populares medicamentos para perder peso como Wegovy y Ozempic, una nueva investigación confirma que estos medicamentos pueden desencadenar efectos secundarios …
Learn MoreGI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss
FRIDAY, Oct. 6, 2023 (HealthDay News) — Use of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss is associated with increased risks for pancreatitis, gastroparesis, and bowel obstruction compared with use of bupropion-naltrexone, acco…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreInflammatory Bowel Disease Tied to Higher Risk for Gout
TUESDAY, Oct. 3, 2023 (HealthDay News) — Inflammatory bowel disease (IBD) is strongly associated with gout, according to a study published online Sept. 1 in JGH Open.Osama Hamid, M.B.B.S., from the Cleveland Clinic, and colleagues investigated the as…
Learn More